| Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta … SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ... Bmj 372, 2021 | 526 | 2021 |
| Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ... Jama 316 (3), 313-324, 2016 | 490 | 2016 |
| Effects of allopurinol on the progression of chronic kidney disease SV Badve, EM Pascoe, A Tiku, N Boudville, FG Brown, A Cass, P Clarke, ... New England Journal of Medicine 382 (26), 2504-2513, 2020 | 361 | 2020 |
| Recent peritonitis associates with mortality among patients treated with peritoneal dialysis N Boudville, A Kemp, P Clayton, W Lim, SV Badve, CM Hawley, ... Journal of the American Society of Nephrology 23 (8), 1398-1405, 2012 | 304 | 2012 |
| Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis B Bose, SV Badve, SS Hiremath, N Boudville, FG Brown, A Cass, ... Nephrology Dialysis Transplantation 29 (2), 406-413, 2014 | 259 | 2014 |
| Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis SV Badve, MA Roberts, CM Hawley, A Cass, AX Garg, H Krum, A Tonkin, ... Journal of the American College of Cardiology 58 (11), 1152-1161, 2011 | 215 | 2011 |
| Biocompatible dialysis fluids for peritoneal dialysis Y Cho, DW Johnson, JC Craig, GFM Strippoli, SV Badve, KJ Wiggins Cochrane Database of Systematic Reviews, 2014 | 151 | 2014 |
| Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis JT Ha, BL Neuen, LP Cheng, M Jun, T Toyama, MP Gallagher, MJ Jardine, ... Annals of internal medicine 171 (3), 181-189, 2019 | 144 | 2019 |
| Biocompatible dialysis fluids for peritoneal dialysis H Htay, DW Johnson, KJ Wiggins, SV Badve, JC Craig, GFM Strippoli, ... Cochrane Database of Systematic Reviews, 2018 | 133 | 2018 |
| Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis DW Johnson, CM Hawley, SP McDonald, FG Brown, JB Rosman, ... Nephrology Dialysis Transplantation 25 (6), 1973-1979, 2010 | 118 | 2010 |
| Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis H Htay, Y Cho, EM Pascoe, D Darssan, AC Nadeau-Fredette, C Hawley, ... Clinical Journal of the American Society of Nephrology 12 (7), 1090-1099, 2017 | 114 | 2017 |
| Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) study EJ See, DW Johnson, CM Hawley, EM Pascoe, SV Badve, N Boudville, ... American Journal of Kidney Diseases 72 (2), 188-197, 2018 | 113 | 2018 |
| Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease C Lo, T Toyama, Y Wang, J Lin, Y Hirakawa, M Jun, A Cass, CM Hawley, ... Cochrane database of systematic reviews, 2018 | 105 | 2018 |
| Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial DW Johnson, SV Badve, EM Pascoe, E Beller, A Cass, C Clark, ... The Lancet Infectious Diseases 14 (1), 23-30, 2014 | 99 | 2014 |
| Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials Y Cho, DW Johnson, S Badve, JC Craig, GFK Strippoli, KJ Wiggins Nephrology Dialysis Transplantation 28 (7), 1899-1907, 2013 | 97 | 2013 |
| Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease W Tang, SP McDonald, CM Hawley, SV Badve, NC Boudville, FG Brown, ... Kidney international 83 (3), 503-510, 2013 | 92 | 2013 |
| Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure PG Lan, PA Clayton, DW Johnson, SP McDonald, M Borlace, SV Badve, ... Peritoneal Dialysis International 36 (6), 623-630, 2016 | 89 | 2016 |
| The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients Y Cho, DW Johnson, SV Badve, JC Craig, GFM Strippoli, KJ Wiggins Kidney international 84 (5), 969-979, 2013 | 89 | 2013 |
| Center effects and peritoneal dialysis peritonitis outcomes: analysis of a national registry H Htay, Y Cho, EM Pascoe, D Darssan, AC Nadeau-Fredette, C Hawley, ... American Journal of Kidney Diseases 71 (6), 814-821, 2018 | 88 | 2018 |
| Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: a randomized clinical trial AB Irish, AK Viecelli, CM Hawley, LS Hooi, EM Pascoe, PA Paul-Brent, ... JAMA internal medicine 177 (2), 184-193, 2017 | 88 | 2017 |
Carmel HawleyUniversity of Queensland在 health.qld.gov.au 的电子邮件经过验证
